Overview
Avasant has named LTIMindtree as an Innovator in its Life Sciences Digital Services 2025 report, recognizing our strong contribution to the digital transformation of Life Sciences enterprises.
The report highlights LTIMindtree’s advanced practice maturity, driven by its value-centric approach across R&D, clinical operations, manufacturing, supply chain, and commercial functions.
LTIMindtree stood out among 38 evaluated service providers for its practice maturity, innovation, and partner ecosystem. Avasant recognized LTIMindtree as one of the top 20 providers delivering the most value in the past year, thanks to our strategic focus and impactful execution in the Life Sciences sector.
Avasant’s Viewpoint: LTIMindtree as an Ideal Digital Transformation Partner for Life Sciences
-
Practice Maturity
Avasant highlights LTIMindtree’s advanced practice maturity in the life sciences sector, driven by its value-centric approach across R&D, clinical operations, manufacturing, supply chain, and commercial functions. With a global footprint of 2,500 professionals across 20 countries, LTIMindtree partners with over 35 life sciences clients, combining deep industry knowledge and technology expertise to deliver differentiated experiences, business agility, and measurable outcomes. Among its standout offerings is the LTIMindtree Enterprise AI platform—a generative AI solution that fast-tracks the concept-to-value cycle while boosting innovation and productivity.
Read More -
Investments & Innovation
Avasant highlights LTIMindtree’s strategic investment in life sciences through its partnership with Voicing.AI, a startup focused on conversational and emotionally intelligent voice technologies. This collaboration enhances customer engagement and operational efficiency, reinforcing LTIMindtree’s vision of embedding AI across the value chain.
Read More -
Partner Ecosystem
The report highlights LTIMindtree’s key industry players, such as Veeva, Medidata, Labware, Labvantage, Tracelink, Clinpal, Biovia, RxLogix, Model N, and Kinaxis. These partnerships have strengthened its life sciences capabilities—especially in commercial and clinical operations—by enabling access to advanced technologies that streamline processes, enhance data management, and improve efficiency across the value chain.
Read More
Why Read the Avasant 2024 RadarView™: Actionable Insights for Life Sciences Leaders
The report focuses on:
- Accelerating drug development with Gen AI
- Market insights in genomics that are transforming healthcare by driving the shift towards personalized medicine
- Industry trends to focus on and real-time analytics to boost sales and customer engagement
4 LTIMindtree Solutions Transforming Life Sciences | Avasant Recognized
-
Lab Information Management Systems (LIMS)
A solution to help in lab operations and regulatory compliance for life sciences companies
-
Decentralized Clinical Trials
An offering to facilitate clinical trial processes by enabling remote patient monitoring
-
AI-augmented Site Selection
An AI solution to locate optimal clinical trial sites for life sciences enterprises
-
Pharmacovigilance
A digital solution to ensure patient safety during clinical trials
